13 results on '"Peter B. Greer"'
Search Results
2. Cone beam computed tomography image guidance within a magnetic resonance imaging-only planning workflow
- Author
-
Laura M. O'Connor, Alesha Quinn, Samuel Denley, Lucy Leigh, Jarad Martin, Jason A Dowling, Kate Skehan, Helen Warren-Forward, and Peter B. Greer
- Subjects
Radiotherapy ,Image-guided radiation therapy ,MRI-only radiotherapy planning ,Cone Beam Computed Tomography ,MRI guided radiation therapy ,Magnetic resonance imaging ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Background and purpose: Magnetic Resonance Imaging (MRI)-only planning workflows offer many advantages but raises challenges regarding image guidance. The study aimed to assess the viability of MRI to Cone Beam Computed Tomography (CBCT) based image guidance for MRI-only planning treatment workflows. Materials and methods: An MRI matching training package was developed. Ten radiation therapists, with a range of clinical image guidance experience and experience with MRI, completed the training package prior to matching assessment. The matching assessment was performed on four match regions: prostate gold seed, prostate soft tissue, rectum/anal canal and gynaecological. Each match region consisted of five patients, with three CBCTs per patient, resulting in fifteen CBCTs for each match region. The ten radiation therapists performed the CBCT image matching to CT and to MRI for all regions and recorded the match values. Results: The median inter-observer variation for MRI-CBCT matching and CT-CBCT matching for all regions were within 2 mm and 1 degree. There was no statistically significant association in the inter-observer variation in mean match values and radiation therapist image guidance experience levels. There was no statistically significant association in inter-observer variation in mean match values for MRI experience levels for prostate soft tissue and gynaecological match regions, while there was a statistically significant difference for prostate gold seed and rectum match regions. Conclusion: The results of this study support the concept that with focussed training, an MRI to CBCT image guidance approach can be successfully implemented in a clinical planning workflow.
- Published
- 2023
- Full Text
- View/download PDF
3. Assessing the impact of magnetic resonance treatment simulation (MRSIM) on target volume delineation and dose to organs at risk for oropharyngeal radiotherapy
- Author
-
Haylea Richardson, Mahesh Kumar, Minh Thi Tieu, Joel Parker, Jason A. Dowling, Jameen Arm, Leah Best, Peter B. Greer, Matthew Clapham, Christopher Oldmeadow, Laura O’Connor, and Chris Wratten
- Subjects
radiation therapy planning ,oropharynx ,MRI ,target volumes ,delineation ,organs at risk dose ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 - Abstract
Abstract Introduction Assessing the use of a radiation therapy (RT) planning MRI performed in the treatment position (pMRI) on target volume delineation and effect on organ at risk dose for oropharyngeal cancer patients planned with diagnostic MRI (dMRI) and CT scan. Methods Diagnostic MRI scans were acquired for 26 patients in a neutral patient position using a 3T scanner (dMRI). Subsequent pMRI scans were acquired on the same scanner with a flat couch top and the patient in their immobilisation mask. Each series was rigidly registered to the patients planning CT scan and volumes were first completed with the CT/dMRI. The pMRI was then made available for volume modification. For the group with revised volumes, two IMRT plans were developed to demonstrate the impact of the modification. Image and registration quality was also evaluated. Results The pMRI registration led to the modification of target volumes for 19 of 26 participants. The pMRI target volumes were larger in absolute volume resulting in reduced capacity for organ sparing. Predominantly, modifications occurred for the primary gross tumour volume (GTVp) with a mean Dice Similarity Coefficient (DSC) of 0.7 and the resulting high risk planning target volume, a mean DSC of 0.89. Both MRIs scored similarly for image quality, with the pMRI demonstrating improved registration quality and efficiency. Conclusions A pMRI provides improvement in registration efficiency, quality and a higher degree of oncologist confidence in target delineation. These results have led to a practice change within our department, where a pMRI is acquired for all eligible oropharyngeal cancer patients.
- Published
- 2022
- Full Text
- View/download PDF
4. Validation of an MRI-only planning workflow for definitive pelvic radiotherapy
- Author
-
Laura M. O’Connor, Jason A. Dowling, Jae Hyuk Choi, Jarad Martin, Helen Warren-Forward, Haylea Richardson, Leah Best, Kate Skehan, Mahesh Kumar, Geetha Govindarajulu, Swetha Sridharan, and Peter B. Greer
- Subjects
MRI radiotherapy planning ,Radiotherapy ,Rectum neoplasms ,Cervix neoplasms ,Endometrium neoplasms ,Anal canal neoplasms ,Medical physics. Medical radiology. Nuclear medicine ,R895-920 ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Purpose Previous work on Magnetic Resonance Imaging (MRI) only planning has been applied to limited treatment regions with a focus on male anatomy. This research aimed to validate the use of a hybrid multi-atlas synthetic computed tomography (sCT) generation technique from a MRI, using a female and male atlas, for MRI only radiation therapy treatment planning of rectum, anal canal, cervix and endometrial malignancies. Patients and methods Forty patients receiving radiation treatment for a range of pelvic malignancies, were separated into male (n = 20) and female (n = 20) cohorts for the creation of gender specific atlases. A multi-atlas local weighted voting method was used to generate a sCT from a T1-weighted VIBE DIXON MRI sequence. The original treatment plans were copied from the CT scan to the corresponding sCT for dosimetric validation. Results The median percentage dose difference between the treatment plan on the CT and sCT at the ICRU reference point for the male cohort was − 0.4% (IQR of 0 to − 0.6), and − 0.3% (IQR of 0 to − 0.6) for the female cohort. The mean gamma agreement for both cohorts was > 99% for criteria of 3%/2 mm and 2%/2 mm. With dose criteria of 1%/1 mm, the pass rate was higher for the male cohort at 96.3% than the female cohort at 93.4%. MRI to sCT anatomical agreement for bone and body delineated contours was assessed, with a resulting Dice score of 0.91 ± 0.2 (mean ± 1 SD) and 0.97 ± 0.0 for the male cohort respectively; and 0.96 ± 0.0 and 0.98 ± 0.0 for the female cohort respectively. The mean absolute error in Hounsfield units (HUs) within the entire body for the male and female cohorts was 59.1 HU ± 7.2 HU and 53.3 HU ± 8.9 HU respectively. Conclusions A multi-atlas based method for sCT generation can be applied to a standard T1-weighted MRI sequence for male and female pelvic patients. The implications of this study support MRI only planning being applied more broadly for both male and female pelvic sites. Trial registration This trial was registered in the Australian New Zealand Clinical Trials Registry (ANZCTR) ( www.anzctr.org.au ) on 04/10/2017. Trial identifier ACTRN12617001406392.
- Published
- 2022
- Full Text
- View/download PDF
5. Quality assurance for MRI-only radiation therapy: A voxel-wise population-based methodology for image and dose assessment of synthetic CT generation methods
- Author
-
Hilda Chourak, Anaïs Barateau, Safaa Tahri, Capucine Cadin, Caroline Lafond, Jean-Claude Nunes, Adrien Boue-Rafle, Mathias Perazzi, Peter B. Greer, Jason Dowling, Renaud de Crevoisier, and Oscar Acosta
- Subjects
quality assurance ,voxel-wise analysis ,population-based evaluation ,synthetic CT assessment ,dosimetric assessment ,MRI-only radiation therapy ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
The quality assurance of synthetic CT (sCT) is crucial for safe clinical transfer to an MRI-only radiotherapy planning workflow. The aim of this work is to propose a population-based process assessing local errors in the generation of sCTs and their impact on dose distribution. For the analysis to be anatomically meaningful, a customized interpatient registration method brought the population data to the same coordinate system. Then, the voxel-based process was applied on two sCT generation methods: a bulk-density method and a generative adversarial network. The CT and MRI pairs of 39 patients treated by radiotherapy for prostate cancer were used for sCT generation, and 26 of them with delineated structures were selected for analysis. Voxel-wise errors in sCT compared to CT were assessed for image intensities and dose calculation, and a population-based statistical test was applied to identify the regions where discrepancies were significant. The cumulative histograms of the mean absolute dose error per volume of tissue were computed to give a quantitative indication of the error for each generation method. Accurate interpatient registration was achieved, with mean Dice scores higher than 0.91 for all organs. The proposed method produces three-dimensional maps that precisely show the location of the major discrepancies for both sCT generation methods, highlighting the heterogeneity of image and dose errors for sCT generation methods from MRI across the pelvic anatomy. Hence, this method provides additional information that will assist with both sCT development and quality control for MRI-based planning radiotherapy.
- Published
- 2022
- Full Text
- View/download PDF
6. Comparison of Synthetic Computed Tomography Generation Methods, Incorporating Male and Female Anatomical Differences, for Magnetic Resonance Imaging-Only Definitive Pelvic Radiotherapy
- Author
-
Laura M. O’Connor, Jae H. Choi, Jason A. Dowling, Helen Warren-Forward, Jarad Martin, and Peter B. Greer
- Subjects
MRI radiotherapy planning ,image-guided radiotherapy ,synthetic CT ,computer-assisted radiotherapy planning ,rectum neoplasms ,cervix neoplasms ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
PurposeThere are several means of synthetic computed tomography (sCT) generation for magnetic resonance imaging (MRI)-only planning; however, much of the research omits large pelvic treatment regions and female anatomical specific methods. This research aimed to apply four of the most popular methods of sCT creation to facilitate MRI-only radiotherapy treatment planning for male and female anorectal and gynecological neoplasms. sCT methods were validated against conventional computed tomography (CT), with regard to Hounsfield unit (HU) estimation and plan dosimetry.Methods and MaterialsPaired MRI and CT scans of 40 patients were used for sCT generation and validation. Bulk density assignment, tissue class density assignment, hybrid atlas, and deep learning sCT generation methods were applied to all 40 patients. Dosimetric accuracy was assessed by dose difference at reference point, dose volume histogram (DVH) parameters, and 3D gamma dose comparison. HU estimation was assessed by mean error and mean absolute error in HU value between each sCT and CT.ResultsThe median percentage dose difference between the CT and sCT was
- Published
- 2022
- Full Text
- View/download PDF
7. Manipulating Medical Image Translation with Manifold Disentanglement.
- Author
-
Siyu Liu 0002, Jason A. Dowling, Craig Engstrom, Peter B. Greer, Stuart Crozier, and Shekhar S. Chandra
- Published
- 2023
- Full Text
- View/download PDF
8. CAN3D: Fast 3D medical image segmentation via compact context aggregation.
- Author
-
Wei Dai, Boyeong Woo, Siyu Liu 0002, Matthew Marques, Craig Engstrom, Peter B. Greer, Stuart Crozier, Jason A. Dowling, and Shekhar S. Chandra
- Published
- 2022
- Full Text
- View/download PDF
9. Clinical validation of the Varian Truebeam intra-fraction motion review (IMR) system for prostate treatment guidance
- Author
-
Guneet Kaur, Joerg Lehmann, Peter B. Greer, Jarad Martin, and John Simpson
- Subjects
Radiological and Ultrasound Technology ,Biomedical Engineering ,Biophysics ,Radiology, Nuclear Medicine and imaging ,Instrumentation ,Biotechnology - Abstract
This study quantified the performance of Intra-fraction Motion Review (IMR) during prostate Stereotactic Body Radiotherapy (SBRT) treatments. IMR was evaluated using prostate motion data from patients treated in an SBRT clinical trial (PROMETHEUS, NCT00587990).IMR measured prostate displacements were compared to those of two 3D motion management methods: Kilovoltage Intra-fraction Motion management (KIM) and MV/kV triangulation. A planning study assessing the impact of a defined prostate motion (2-5 mm) on the PTV coverage with and without IMR was performed. A clinically relevant IMR search region for prostate cancer SBRT treatments was determined using a customised anthropomorphic pelvis phantom with implanted gold seeds and a motion platform. IMR showed submillimeter agreement with corresponding 2D projections from both KIM and MV/kV triangulation. However, IMR detected actual displacements consistently in considerably fewer frames than KIM (3D), with the actual numbers depending on the settings. The Default Search Region (DSR) method employing a circular search region proved superior to user-contoured structures in detecting clinically relevant prostate motion. Reducing the DSR search region radius can reduce the impact of the 2D nature of IMR and improve the detectability of actual motion (by 10% per 0.5 mm reduction) but must be balanced against increased beam interruptions from minor, clinically irrelevant motion. The use of IMR for SBRT prostate treatments has the potential to improve target dose coverage (minimum dose to 98% of the PTV, D98%) by 20% compared to treatment without IMR. Calculated D98% of IMR monitored treatments with motion was within 1.5% of plans without motion.
- Published
- 2022
- Full Text
- View/download PDF
10. The dosimetric error due to uncorrected tumor rotation during real‐time adaptive prostate stereotactic body radiation therapy
- Author
-
Chandrima Sengupta, Simon Skouboe, Thomas Ravkilde, Per Rugaard Poulsen, Doan Trang Nguyen, Peter B. Greer, Trevor Moodie, Nicholas Hardcastle, Amy J. Hayden, Sandra Turner, Shankar Siva, Keen‐Hun Tai, Jarad Martin, Jeremy T. Booth, Ricky O'Brien, and Paul J. Keall
- Subjects
motion management ,motion-induced dose error ,tumor motion ,General Medicine - Abstract
Background: During prostate stereotactic body radiation therapy (SBRT), prostate tumor translational motion may deteriorate the planned dose distribution. Most of the major advances in motion management to date have focused on correcting this one aspect of the tumor motion, translation. However, large prostate rotation up to 30° has been measured. As the technological innovation evolves toward delivering increasingly precise radiotherapy, it is important to quantify the clinical benefit of translational and rotational motion correction over translational motion correction alone. Purpose: The purpose of this work was to quantify the dosimetric impact of intrafractional dynamic rotation of the prostate measured with a six degrees-of-freedom tumor motion monitoring technology. Methods: The delivered dose was reconstructed including (a) translational and rotational motion and (b) only translational motion of the tumor for 32 prostate cancer patients recruited on a 5-fraction prostate SBRT clinical trial. Patients on the trial received 7.25 Gy in a treatment fraction. A 5 mm clinical target volume (CTV) to planning target volume (PTV) margin was applied in all directions except the posterior direction where a 3 mm expansion was used. Prostate intrafractional translational motion was managed using a gating strategy, and any translation above the gating threshold was corrected by applying an equivalent couch shift. The residual translational motion is denoted as (Formula presented.). Prostate intrafractional rotational motion (Formula presented.) was recorded but not corrected. The dose differences from the planned dose due to (Formula presented.) + (Formula presented.), ΔD((Formula presented.) + (Formula presented.)) and due to (Formula presented.) alone, ΔD((Formula presented.)), were then determined for CTV D98, PTV D95, bladder V6Gy, and rectum V6Gy. The residual dose error due to uncorrected rotation, (Formula presented.) was then quantified: (Formula presented.) = ΔD((Formula presented.) + (Formula presented.)) - ΔD((Formula presented.)). Results: Fractional data analysis shows that the dose differences from the plan (both ΔD((Formula presented.) + (Formula presented.)) and ΔD((Formula presented.))) for CTV D98 was less than 5% in all treatment fractions. ΔD((Formula presented.) + (Formula presented.)) was larger than 5% in one fraction for PTV D95, in one fraction for bladder V6Gy, and in five fractions for rectum V6Gy. Uncorrected rotation, (Formula presented.) induced residual dose error, (Formula presented.), resulted in less dose to CTV and PTV in 43% and 59% treatment fractions, respectively, and more dose to bladder and rectum in 51% and 53% treatment fractions, respectively. The cumulative dose over five fractions, ∑D((Formula presented.) + (Formula presented.)) and ∑D((Formula presented.)), was always within 5% of the planned dose for all four structures for every patient. Conclusions: The dosimetric impact of tumor rotation on a large prostate cancer patient cohort was quantified in this study. These results suggest that the standard 3–5 mm CTV-PTV margin was sufficient to account for the intrafraction prostate rotation observed for this cohort of patients, provided an appropriate gating threshold was applied to correct for translational motion. Residual dose errors due to uncorrected prostate rotation were small in magnitude, which may be corrected using different treatment adaptation strategies to further improve the dosimetric accuracy.
- Published
- 2022
- Full Text
- View/download PDF
11. SEAFARER – A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practice
- Author
-
Joerg Lehmann, Mohammad Hussein, Miriam A. Barry, Shankar Siva, Alisha Moore, Michael Chu, Patricia Díez, David J. Eaton, Jeffrey Harwood, Peta Lonski, Elizabeth Claridge Mackonis, Carole Meehan, Rushil Patel, Xenia Ray, Maddison Shaw, Justin Shepherd, Gregory Smyth, Therese S. Standen, Brindha Subramanian, Peter B. Greer, and Catharine H. Clark
- Subjects
Clinical Trials as Topic ,Quality Assurance, Health Care ,Oncology ,Radiotherapy Planning, Computer-Assisted ,Humans ,Radiotherapy Dosage ,Radiology, Nuclear Medicine and imaging ,Radiotherapy, Intensity-Modulated ,Hematology ,Radiometry - Abstract
The quality of radiotherapy delivery has been shown to significantly impact clinical outcomes including patient survival. To identify errors, institutions perform Patient Specific Quality Assurance (PSQA) assessing each individual radiotherapy plan prior to starting patient treatments. Externally administered Dosimetry Audits have found problems despite institutions passing their own PSQA. Hence a new audit concept which assesses the institution's ability to detect errors with their routine PSQA is needed.Purposefully introduced edits which simulated treatment delivery errors were embedded into radiation treatment plans of participating institutions. These were designed to produce clinically significant changes yet were mostly within treatment delivery specifications. Actual impact was centrally assessed for each plan. Institutions performed PSQA on each plan, without knowing which contained errors.Seventeen institutions using six radiation treatment planning systems and two delivery systems performed PSQA on twelve plans each. Seventeen erroneous plans (across seven institutions) passed PSQA despite causing5% increase in spinal cord dose relative to the original plans. Six plans (from four institutions) passed despite a10% increase.This novel audit concept evolves beyond testing an institution's ability to deliver a single test case, to increasing the number of errors caught by institutions themselves, thus increasing quality of radiation therapy and impacting every patient treated. Administered remotely this audit also provides advantages in cost, environmental impact, and logistics.
- Published
- 2022
- Full Text
- View/download PDF
12. Local quality assessment of patient specific synthetic-CT via voxel-wise analysis
- Author
-
Hilda Chourak, Anaïs Barateau, Jean-Claude Nunes, Peter B. Greer, Safaa Tahri, Caroline Lafond, Renaud de Crevoisier, Jason Dowling, and Oscar Acosta
- Published
- 2022
- Full Text
- View/download PDF
13. Verification of stereotactic radiosurgery plans for multiple brain metastases using a virtual phantom-based procedure
- Author
-
Juan-Francisco Calvo-Ortega, Peter B. Greer, Sandra Moragues-Femenía, Miguel Pozo-Massó, and Joan Casals-Farran
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Abstract
The purpose of this study was to describe the use of the VIPER software for patient-specific quality assurance (PSQA) of single-isocenter multitarget (SIMT) stereotactic radiosurgery (SRS) plans.Twenty clinical of intensity-modulated (IMRT) SIMT SRS plans were reviewed. A total of 88 brain metastases were included. Number of lesions per plan and their individual volumes ranged from 2 to 35 and from 0.03 to 32.8 cmThe averages (± 1 SD) of the 3D GPRs over the 20 SRS plans were: 99.9 ± 0.2%, 99.7 ± 0.3%, 99.6 ± 0.5%, 99.3 ± 0.9%,99.1 ± 1.6%, 99.0 ± 1.6%, and 98.5 ± 3.3%, for dose thresholds of 10%, 20%, 30%, 50%, 70%, 80% and 90% respectively.This work shows the feasibility of the VIPER software for PSQA of SIMT SRS plans, being a reliable alternative to commercially available 2D detector arrays.
- Published
- 2022
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.